| Affected protein | MicroRNA | Related cancer (cell lines or patients) |
| ABCC5(+) | miR-101 [74] | HCC | ABCC1(+) | miR-199 [74] | HCC | ABCC1(-) | miR-326 [75] | Breast cancer | ABCC2(-) | miR-397 [76] | Hepatoblastoma cell | ABCC3(-), ABCC6(-) | miR-9 [77] | Glioma cell | ABCC4(-) | miR-125 [74] | Hepatocellular carcinoma | ABCG2(-) | miR-212 [78] | Myelogenous leukemia | ABCG2(-) | miR-328 [78–81] | Breast cancer, retinoblastoma, myelogenous leukemia, and CRC | ABCG2(-) | miR-519 [79, 82, 83] | Colon cancer, breast cancer, and retinoblastoma | DPYD(-) | miR-134 [84] | HCC, lung cancer | DPYD(-) | miR-494 [85] | Colon cancer | DPYD(-) | miR-582 [84] | HCC | DPYD(-), P-gp(-) | miR-302 [86, 87] | HCC and breast cancer | P-gp(-) | miR-103 [88] | Gastric cancer | P-gp(-) | miR-107 [88] | Gastric cancer | P-gp(-) | miR-129 [89] | Gastric cancer | P-gp(+) | miR-130 [90] | Ovarian cancer | P-gp(-) | miR-137 [91] | Breast cancer | P-gp(-) | miR-138 [92] | Leukemia | P-gp(-) | miR-298 [93] | Breast cancer | P-gp(-) | miR-30 [94] | Gastric cancer | P-gp(-) | miR-331 [95] | Chronic myelogenous leukemia | P-gp(-), ABCB1(-) | miR-451[96–98] | Breast cancer, CRC | P-gp(-) | miR-506 [99] | CRC | P-gp(-), ABCG2(-) | miR-145 [100, 101] | Colon carcinoma | P-gp(-), ABCG2(-), ABCG5(-) | miR-200 [102, 103] | Breast cancer and melanomas | TP(-), DPYD(-) | miR-21 [30] | CRC | TS(-) | miR-192 [104] | CRC | TS(-) | miR-196 [37] | Rectal cancer | TS(-) | miR-197 [105] | CRC | TS(-) | miR-203 [106] | CRC | TS(-) | miR-215 [37, 104, 107–110] | CRC, soft tissue sarcoma, renal cancer, and head and neck cancer | P-gp(+) | miR-218 [38] | CRC | TS(-) | miR-24 [107] | Soft tissue sarcoma | TS(-) | miR-433 [111] | HCC | TS(-) | miR-450 [37] | Rectal cancer | TS(-) | miR-99 [37] | Rectal cancer | ABCC5(-)TS(-) | Let-7e [37, 74] | Rectal cancer, HCC | TS(-), ABCC3(-) | miR-192 [104, 112] | CRC and esophageal adenocarcinoma | TS(-), ABCC3(-) | miR-193 [112] | Esophageal adenocarcinoma | TS(-), ABCC3(-) | miR-378 [112] | Esophageal adenocarcinoma | TS(-), ABCG2(-) | miR-520 [80, 113–115] | HCC, pancreatic cancer, and retinoblastoma | TS(-), DPYD(-), P-gp(-), ABCC3(-) | miR-27 [37, 38, 74, 93, 95, 96, 102, 105, 116, 117] | CRC, HCC, lung cancer, gastric cancer, breast cancer, esophageal adenocarcinoma, leukemia, and ovarian cancer |
|
|